AGF Management’s ResMed RMD Stock Holding History

AGF Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,838	Closed	-$488K	–	754
2023 Q4	$488K	Sell	2,838 -84	-3%	-$12.9K	﹤0.01%	630
2023 Q3	$432K	Buy	+2,922	New	+$528K	﹤0.01%	653

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AGF Management's RMD Position: Q1 2024 in Review

AGF Management sold out of ResMed (RMD) in Q1 2024, closing a stake of 2,838 shares — an estimated $488K sold.

AGF Management first reported a position in RMD in Q3 2023 and held it in 2 quarters. The position peaked at $488K in Q4 2023. 718 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

AGF Management reported no remaining ResMed position as of Q1 2024 after selling out during the quarter.
AGF Management sold 2,838 ResMed shares in Q1 2024, an estimated $488K.
AGF Management first reported a position in ResMed in Q3 2023 and held it in 2 quarters.
AGF Management's ResMed position peaked at $488K in Q4 2023.
718 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on AGF Management's 13F filing for Q1 2024, filed 13 May 2024.